Product Overview
The DRI Amphetamines assay is intended for the qualitative or semi-quantitative determination of amphetamine and methamphetamine in human urine
Product Features
- The DRI® Amphetamines assay is a liquid ready-to-use homogeneous enzyme immunoassay
- Analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this assay
Product Specifications
| Catalog Number/SKU | MF-5390012196 |
| Application | Toxicology Reagent |
|---|---|
| For Use With | For Automated Clinical Chemistry Analyzers |
| Form | Liquid |
| Sample Type | Urine Sample |
| Specialty | Toxicology |
| Storage Requirements | Requires Refrigeration |
| Test Category | Drugs of Abuse |
| Test Method | Homogeneous Enzyme Immunoassay (HEIA) |
| Test Name | Amphetamines (AMP) |
| Test Type | Single Drug |
| Volume | 2 X 100 mL / 1 x 500 ml |
